Cerebrolysin is a protein-based agent that contains small-molecule biologically active neuropeptides. Neuropeptides penetrate through the blood-brain barrier and act directly on nervous cells.
Cerebrolysin possesses the unique organo-specific multimodal action on the brain manifested in metabolic regulation, functional neuromodulation, neuroprotective action, neurotrophic activity.
Cerebrolysin has been studied in thousands of patients in double-blind studies with consistently excellent results.
Cerebrolysin is used to treat the following conditions:
Contraindications and Cautions:
- Organic, metabolic and neurodegenerative disorders of the brain, especially senile dementia of type
- Post-apoplectic complications
- Craniocerebral trauma
- Post operative trauma
- Cerebral contusion
- Ischemic stroke
- Chromic cerebrovascular pathology
- Mental retardation
- Disorders associated with attention deficiency in children
- Senile dementia
- Alzheimer's disease
- Endogenous depression
Special care is indicated in cases of:
- Allergic diathesis
- Epileptic conditions and grand mal convulsions; Cerebrolysin treatment may result in an increase in the frequency of seizures
- Although there are no indications that Cerebrolysin causes renal stress, the product should not be administered in the presence of existing severe renal insufficiency
Cerebrolysin should be used with caution in pregnancy(1 trimester and breastfeeding)
There are possible side-effects associated with this medicine that can affect individuals in different ways. If a side effect is stated here, that does not necessarily mean the fact that all people using Cerebrosylin will experience it or any other.
Cerebrolysin is generally well tolerated. If injected too quickly it may cause a moderate heat sensation. In extremely rare cases hypersensitivity reactions manifest themselves as chills, headaches, or slight increases in body temperature of the patient. In no case to date has the undesirable effect persisted or proved threatening to the patient's health.
The side effects listed above may not include all of the side effects reported by the drug's manufacturer. For more information about any other possible risks associated with Cerebrolysin, please read the information provided with Cerebrolysin or consult your doctor or pharmacist.
It is important to tell your doctor or pharmacist what medicines you are already taking, including those bought without a prescription and herbal medicines, before you start treatment with Cerebrolysin. Similarly, check with your doctor or pharmacist before taking any new medication while taking this one, to ensure that the combination is safe.
On the basis of Cerebrolysin's pharmacological profile, special attention should be given to possible additive effects when used in conjunction with anti-depressants or MAO-inhibitors. In such cases it is recommended that the dose of the anti-depressant is lowered.
Cerebrolysin should not be mixed with balanced amino acid solutions in an infusion.